20 Best Biotech Stocks Under $20 to Buy Now

Page 5 of 18

14. Korro Bio, Inc. (NASDAQ:KRRO)

Number of Hedge Fund Holders: 22

Stock Price: $11.69

Korro Bio, Inc. (NASDAQ:KRRO) is next on our list of best biotech stocks.

TheFly reported on January 29 that H.C. Wainwright upgraded KRRO from Neutral to Buy with a $20 price target. The firm highlighted KRRO-121 as a second, independently risk-mitigated asset and described it as a “call option” that is separate from the company’s earlier KRRO-110 program. H.C. Wainwright highlighted the independent potential of KRRO-121 by pointing out that KRRO’s shares are trading close to zero enterprise value.

Similarly, on the same day, Chardan Capital also upgraded Korro Bio, Inc. (NASDAQ:KRRO) from Neutral to Buy with a $15 price target following the company’s analyst day. The upgrade reflected the firm’s view that KRRO has “turned the page,” supported by strong preclinical data for KRRO-121.

Korro Bio, Inc. (NASDAQ:KRRO) is a biopharmaceutical company developing precision genetic medicines by editing RNA to treat rare and prevalent diseases. Using its proprietary OPERA platform, KRRO advances RNA‑editing therapies, including clinical and preclinical programs.

Page 5 of 18